Back Pain Doctor
Shoulder Calcific Tendinopathy
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Shoulder calcific tendinopathy is a specific rotator cuff condition where calcium forms inside a tendon. It is a specific process, distinct from general “wear and tear”, and it is not the same as osteoarthritis. Symptoms can range from mild persistent discomfort to severe acute pain when the calcium deposit becomes highly inflamed.
Assessment usually considers the pattern of pain, shoulder range of motion, rotator cuff strength and imaging findings. Ultrasound and x-ray can help confirm the presence, size and character of a calcific deposit.
Management depends on the clinical phase. In an acute inflammatory flare, pain control and restoring sleep may be the immediate priority. In more persistent cases, treatment may include physiotherapy, load modification, focused shockwave therapy, ultrasound-guided injection or referral for other procedures when appropriate. The aim is to match treatment to the deposit, the shoulder mechanics and the person’s functional goals.
Common symptoms
- Pain over the outer shoulder or upper arm
- Pain with reaching, lifting or lying on the affected side
- Sudden severe pain during an inflammatory flare
- Reduced shoulder movement due to pain or guarding
Commonly seen in
Evidence for twelve treatment options in shoulder calcific tendinopathy
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
The strongest evidence here is what does not work. In a placebo-surgery controlled trial, arthroscopic subacromial decompression gave no benefit over a sham operation or over exercise therapy, at two years, at five, and at ten (Paavola, BMJ 2018; Paavola, Br J Sports Med 2020; Kanto, BMJ 2025). A network meta-analysis of 54 trials and 3,893 patients found shoulder-specific exercise reduced pain out to 52 weeks, and that adding injections, manual therapy or electrotherapy to it added little (Silveira, PLoS One 2024).
Pairing reviewed 2026-09-02.
Where it fits
Loading the shoulder properly is the treatment. An injection is occasionally used to settle pain enough to start, which is a different claim from treating the problem.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
No trial has tested trigger point injection in calcific tendinopathy. The needling literature at this tendon is barbotage - ultrasound-guided needling and lavage of the calcium deposit itself, which is a different procedure aimed at a different structure. In a randomised trial of 48 people, barbotage added to a subacromial corticosteroid injection was ahead at one year but by five years the shoulder scores no longer differed (Constant 90 against 87, p = 0.58), although 4 of the barbotage group went on to further treatment against 16 of those given the corticosteroid alone (de Witte, Am J Sports Med 2017). The Dutch Orthopaedic Association guideline lists shockwave or ultrasound-guided needling as the options for calcific disease (Diercks, Acta Orthop 2014).
Pairing reviewed 2026-09-11.
Where it fits
Considered only where examination finds a separate tender muscle band reproducing part of your pain. Barbotage of the deposit is a different procedure and is discussed under its own heading.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Good support
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Bursal and sheath targets are small, often deep, and poorly identified by surface landmarks; ultrasound guidance improved accuracy across shoulder girdle targets and improved efficacy where the target was a sheath rather than a large space (Aly, Br J Sports Med 2014).
Pairing reviewed 2026-08-30.
Where it fits
Where an inflamed bursa is the identified target, this is a reasonable step, with the number of injections kept low. See the note on cortisone.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Good support
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched 18 October 2026: radial shockwave with calcific or calcifying shoulder tendinopathy (19 records), a randomised-trial pass (6) and a systematic-review pass (19), all read from their abstracts. The old line here said the trials used focused devices; several used radial. In 90 people with X-ray-confirmed calcific tendinitis, radial shockwave beat a less active look-alike treatment on pain and shoulder function after treatment and at six months, and the deposit disappeared completely in 87% of treated shoulders against none of the controls (Cacchio, Phys Ther 2006). In 80 people, adding four weekly radial sessions to physiotherapy gave more improvement in pain, movement and arm function than physiotherapy alone, measured at the end of treatment only (Duymaz, Arch Rheumatol 2019). A network meta-analysis of 14 randomised trials and 1,105 people found radial shockwave, high-energy focused shockwave and ultrasound-guided needling all reduced pain and cleared the deposit, with high-energy focused shockwave best for function (Wu, Arch Phys Med Rehabil 2017). Against that: in a sham-controlled trial of 143 people with shoulder pain, all doing supervised exercise, the benefit in the subgroup with calcification (12.8 points on the SPADI at 24 weeks) had gone by one year (Kvalvaag, Am J Sports Med 2017; Eur J Phys Rehabil Med 2018), and ultrasound-guided needling did better than radial shockwave at six weeks in 25 people, with no difference in pain at one year (de Boer, J Orthop 2017). Both positive trials are single-centre.
Pairing reviewed 2026-10-18.
Where it fits
A reasonable non-invasive option alongside a shoulder loading program when a calcific deposit stays painful. High-energy focused shockwave has the larger evidence base and ultrasound-guided needling clears the deposit fastest, so the three are usually discussed together.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Good support
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
High-energy focused shockwave is better than placebo for pain, shoulder function and resorption of the calcific deposit (Bannuru, Ann Intern Med 2014; Gerdesmeyer, JAMA 2003). A 27-study review concluded it is reasonable to trial alongside ultrasound-guided needling before considering surgery (Angileri, J Shoulder Elbow Surg 2023).
Pairing reviewed 2026-08-30.
Where it fits
One of the strongest indications for focused shockwave anywhere. Ultrasound-guided needling clears the deposit more reliably; the two are often discussed together.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Worth discussing
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Platelet-rich plasma here is an add-on to needling the calcium, not a treatment in its own right. In a double-blind randomised trial, 80 people had ultrasound-guided needle aspiration of the deposit followed by either platelet-rich plasma or corticosteroid: platelet-rich plasma was worse at six weeks, better at six months, and the same at one and two years, with fewer people needing a second procedure (24% against 49%) but more complications, mostly frozen shoulder (6 against 1). The authors concluded corticosteroid remained their treatment of choice (Oudelaar, Am J Sports Med 2021). A network meta-analysis of 19 randomised trials and 1,160 patients ranked platelet-rich plasma highest for improving shoulder function, at 85% probability, though not for pain (Moggio, Orthop Surg 2025).
Pairing reviewed 2026-09-04.
Where it fits
Worth discussing, and only after the calcium has been needled. The barbotage is what does the work, and platelet-rich plasma is a choice about what goes in afterwards. It buys less early relief than cortisone and costs more, so the case for it is where you want to avoid a repeat procedure or repeated cortisone. The frozen-shoulder signal in that trial is part of the conversation.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible: no studies
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No trial has tested prolotherapy in calcific tendinopathy of the shoulder. The only published report is a single case in which a large deposit resorbed after ultrasound-guided prolotherapy given alongside physiotherapy and a nutritional regimen, so the prolotherapy cannot be separated from the rest (Yoon, Cureus 2026).
Pairing reviewed 2026-09-05.
Where it fits
Not the treatment to reach for here. Barbotage, shockwave and a loading programme are the options with actual evidence in calcific disease, and they target the deposit directly.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used for tendons
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Searched 12 November 2026 (PubMed: hyaluronic acid, hyaluronate, hyaluronan or viscosupplementation with calcific or calcifying tendinitis or tendinopathy, 3 records; a second search of hyaluronic acid with calcific or calcifying and shoulder or rotator cuff, 6 records). No study has tested hyaluronic acid for a calcium deposit in the rotator cuff. The shoulder tendon trials found either state that they enrolled non-calcific tendon pain (Frizziero, J Sports Med Phys Fitness 2017) or studied rotator cuff tendon pain generally, where subacromial injections gave a benefit that the authors describe as encouraging but not lasting (Merolla, Musculoskelet Surg 2013).
Pairing reviewed 2026-11-12.
Where it fits
Not offered for this. It does nothing to the calcium deposit. Where the deposit itself needs treating, the options with evidence are set out in the other rows of this guide.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. No studies found
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
No study of perineural injection in calcific tendinopathy. Searching perineural injection, neural prolotherapy, glucopuncture, dextrose and D5W terms against calcific tendinitis and calcific tendinopathy returns one shoulder report, and it describes a different treatment: a single case in which 10% dextrose was injected into the glenohumeral joint and the subacromial space alongside physiotherapy and nutritional supplements, with the deposit largely resorbed at two weeks (Yoon, Cureus 2026). Nothing in it concerns a nerve, and one uncontrolled case cannot show cause.
Pairing reviewed 2026-09-16.
Where it fits
Considered only where hypersensitive skin overlies the painful area. It does nothing to the calcium deposit itself.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No study of hydrodissection in calcific tendinopathy was found: hydrodissection, hydrorelease and hydrodilatation searched against calcific, rotator cuff and subacromial terms returned no calcific-specific record. The fluid-based procedure that has been studied here is barbotage (needling and washing out the calcium deposit), which targets the deposit rather than a nerve or tissue plane and is a different procedure. In 48 people randomised to barbotage plus a subacromial cortisone injection or the injection alone, the one-year advantage had gone by five years, although 4 of the barbotage group needed further treatment against 16 of the others (de Witte, Am J Sports Med 2017).
Pairing reviewed 2026-09-29.
Where it fits
Only where a nerve is separately implicated. Barbotage, if it is being considered, is a separate conversation.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other shoulder conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
Frequently asked questions
Is calcific tendinopathy the same as arthritis?
Does the calcium always need to be removed?
Can shockwave help calcific tendinopathy?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment